Lynn Tanoue, MD, MBA

• Beth Anne Jones
• Brenda Cartmel
• Carrie A Redlich
• Cary Gross
• Christopher Gange
• Daniel Boffa
• David Rimm
• Frederick Wilson
• Kathleen Akgün
• Lingeng Lu
• Lisa Fucito
• Lloyd Friedman
• Lori Bastian
• Margaret Pisani
• Mark Russi
• Melinda Irwin
• Patrick G. O'Connor
• Peter S. Aronson
• Richard Matthay
• Robert Homer
• Roy S. Herbst
• Scott Gettinger

Lung Neoplasms; Respiration; Thoracic Neoplasms; Pulmonary Medicine

• Evidence of Racial Disparities in the Lung Cancer Screening Process: a Systematic Review and Meta-AnalysisKunitomo Y, Bade B, Gunderson CG, Akgün KM, Brackett A, Tanoue L, Bastian LA. Evidence of Racial Disparities in the Lung Cancer Screening Process: a Systematic Review and Meta-Analysis Journal Of General Internal Medicine 2022, 37: 3731-3738. PMID: 35838866, PMCID: PMC9585128, DOI: 10.1007/s11606-022-07613-2.
• NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. Journal Of The National Comprehensive Cancer Network : JNCCN 2022, 20: 754-764. PMID: 35830884, DOI: 10.6004/jnccn.2022.0036.
• RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition.Hunihan L, Zhao D, Lazowski H, Li M, Qian Y, Abriola L, Surovtseva YV, Muthusamy V, Tanoue LT, Rothberg B, Schalper KA, Herbst RS, Wilson FH. RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition. Clinical Cancer Research 2022, 28: 3091-3103. PMID: 35247929, PMCID: PMC9288503, DOI: 10.1158/1078-0432.ccr-21-4291.
• Standardizing the Reporting of Incidental, Non-Lung Cancer (Category S) Findings Identified on Lung Cancer Screening Low-Dose CT ImagingTanoue LT, Sather P, Cortopassi I, Dicks D, Curtis A, Michaud G, Bader A, Gange C, Detterbeck F, Killam J. Standardizing the Reporting of Incidental, Non-Lung Cancer (Category S) Findings Identified on Lung Cancer Screening Low-Dose CT Imaging CHEST Journal 2022, 161: 1697-1706. PMID: 35032477, DOI: 10.1016/j.chest.2021.12.662.
• Women and Lung CancerTanoue LT. Women and Lung Cancer Clinics In Chest Medicine 2021, 42: 467-482. PMID: 34353452, DOI: 10.1016/j.ccm.2021.04.007.
• Racial Differences in Adherence to Lung Cancer Screening Follow-up A Systematic Review and Meta-analysisKunitomo Y, Bade B, Gunderson CG, Akgün KM, Brackett A, Cain H, Tanoue L, Bastian LA. Racial Differences in Adherence to Lung Cancer Screening Follow-up A Systematic Review and Meta-analysis CHEST Journal 2021, 161: 266-275. PMID: 34390706, DOI: 10.1016/j.chest.2021.07.2172.
• A Systematic Review of Racial Disparities in Lung Cancer Screening AdherenceKunitomo Y, Bade B, Gunderson C, Akgun K, Brackett A, Tanoue L, Cain H, Bastian L. A Systematic Review of Racial Disparities in Lung Cancer Screening Adherence 2021, a1737-a1737. DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1737.
• Changes in Quality of Life in Lung Cancer Survivors: Trend and PredictorsBade B, Zhao J, Li F, Tanoue L, Silvestri G, Irwin M. Changes in Quality of Life in Lung Cancer Survivors: Trend and Predictors 2021, a4793-a4793. DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4793.
• “Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”Bade BC, Gan G, Li F, Lu L, Tanoue L, Silvestri GA, Irwin ML. “Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study” BMC Cancer 2021, 21: 352. PMID: 33794808, PMCID: PMC8015735, DOI: 10.1186/s12885-021-08084-0.
• A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive HypoxemiaKunitomo Y, Young G, Datta R, Korn LL, Tanoue L, Gautam S. A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive Hypoxemia CHEST Journal 2020, 158: e191-e196. PMID: 33036118, PMCID: PMC7533682, DOI: 10.1016/j.chest.2020.06.020.
• Lung Cancer StagingTanoue LT. Lung Cancer Staging Clinics In Chest Medicine 2020, 41: 161-174. PMID: 32402353, DOI: 10.1016/j.ccm.2020.02.006.
• The Impact of Structured Reporting of Incidental (Category S) Findings Identified on Lung Cancer Screening LDCTs on Management by Primary Care ProvidersKunitomo Y, Sather P, Killam J, Pisani M, Slade M, Tanoue L. The Impact of Structured Reporting of Incidental (Category S) Findings Identified on Lung Cancer Screening LDCTs on Management by Primary Care Providers 2020, a6463-a6463. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6463.
• Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel ReportMazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel Report CHEST Journal 2020, 158: 406-415. PMID: 32335067, PMCID: PMC7177089, DOI: 10.1016/j.chest.2020.04.020.
• Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel ReportMazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel Report Journal Of The American College Of Radiology 2020, 17: 845-854. PMID: 32485147, PMCID: PMC7177099, DOI: 10.1016/j.jacr.2020.04.024.
• Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel ReportMazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report Radiology Imaging Cancer 2020, 2: e204013. PMID: 33778716, PMCID: PMC7233408, DOI: 10.1148/rycan.2020204013.
• Lessons for Precision Medicine from Lung CancerBade B, Foley F, Tanoue L. Lessons for Precision Medicine from Lung Cancer 2020, 201-223. DOI: 10.1007/978-3-030-31507-8_14.
• Safely and Effectively Evaluating Computed Tomography–detected Lung Lesions. Much Work to Be DoneBurks AC, Gould MK, Silvestri G, Yarmus LB, Sears CR, Arenberg DA, Gonzalez AV, Slatore CG, Tanner NT, Vachani A, Nana-Sinkam P, Fuster MM, Wahidi MM, Tanoue LT, Rivera MP. Safely and Effectively Evaluating Computed Tomography–detected Lung Lesions. Much Work to Be Done Annals Of The American Thoracic Society 2019, 16: 1360-1362. PMID: 31437410, DOI: 10.1513/annalsats.201905-389ps.
• Prevalence and 12-Month Downstream Costs of Incidental Findings in a Single-Center Lung Cancer Screening ProgramGodfrey M, Sather P, Tanoue L, Pisani M. Prevalence and 12-Month Downstream Costs of Incidental Findings in a Single-Center Lung Cancer Screening Program 2019, a4474-a4474. DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4474.
• Addressing Gender Inequality in Our Disciplines: Report from the Association of Pulmonary, Critical Care, and Sleep Division ChiefsThomson CC, Riekert KA, Bates CK, Jena AB, Borok Z, McCallister JW, Schnapp LM, Lama VN, Kraft M, Davis SD, Finn P, Carson SS, Beck JM, Powell CA, Tanoue LT, Kaminski N, Dixon AE. Addressing Gender Inequality in Our Disciplines: Report from the Association of Pulmonary, Critical Care, and Sleep Division Chiefs Annals Of The American Thoracic Society 2018, 15: 1382-1390. PMID: 30153425, DOI: 10.1513/annalsats.201804-252ar.
• Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected doseYe Q, Wu J, Lu Y, Naganawa M, Gallezot JD, Ma T, Liu Y, Tanoue L, Detterbeck F, Blasberg J, Chen MK, Casey M, Carson RE, Liu C. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose Physics In Medicine And Biology 2018, 63: 175015. PMID: 30095083, PMCID: PMC6158045, DOI: 10.1088/1361-6560/aad97f.
• Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research StatementRivera MP, Tanner NT, Silvestri GA, Detterbeck FC, Tammemägi MC, Young RP, Slatore CG, Caverly TJ, Boyd CM, Braithwaite D, Fathi JT, Gould MK, Iaccarino JM, Malkoski SP, Mazzone PJ, Tanoue LT, Schoenborn NL, Zulueta JJ, Wiener RS. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement American Journal Of Respiratory And Critical Care Medicine 2018, 198: e3-e13. PMID: 30004250, DOI: 10.1164/rccm.201805-0986st.
• Lung Cancer Screening at Smilow Cancer Hospital and Yale Cancer CenterCartmel B, Jones B, Fucito L, Tanoue L, Sather P, Toll B. Lung Cancer Screening at Smilow Cancer Hospital and Yale Cancer Center Journal Of Thoracic Oncology 2017, 12: s1544. DOI: 10.1016/j.jtho.2017.06.054.
• P1.05-017 The Prognostic Impact of EGFR, KRAS and TP53 Somatic Mutations in Curatively Resected Early-Stage Lung Adenocarcinomas Topic: Translational Research and BiomarkersRothberg B, Das R, Jackson L, Lazowski H, Bai Y, O'Neill D, Roberts S, Rothberg J, Herbst R, Kim A, Boffa D, Rimm D, Detterbeck F, Tanoue L. P1.05-017 The Prognostic Impact of EGFR, KRAS and TP53 Somatic Mutations in Curatively Resected Early-Stage Lung Adenocarcinomas Topic: Translational Research and Biomarkers Journal Of Thoracic Oncology 2017, 12: s623-s624. DOI: 10.1016/j.jtho.2016.11.801.
• The Eighth Edition Lung Cancer Stage ClassificationDetterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage Classification CHEST Journal 2016, 151: 193-203. PMID: 27780786, DOI: 10.1016/j.chest.2016.10.010.
• Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare PopulationErb CT, Su KW, Soulos PR, Tanoue LT, Gross CP. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population Lung Cancer 2016, 99: 200-207. PMID: 27565940, PMCID: PMC5003420, DOI: 10.1016/j.lungcan.2016.07.017.
• Lung cancer screeningTanoue LT. Lung cancer screening Current Opinion In Pulmonary Medicine 2016, 22: 327-335. PMID: 27159896, DOI: 10.1097/mcp.0000000000000287.
• The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung CancerDetterbeck FC, Bolejack V, Arenberg DA, Crowley J, Donington JS, Franklin WA, Girard N, Marom EM, Mazzone PJ, Nicholson AG, Rusch VW, Tanoue LT, Travis WD, Asamura H, Rami-Porta R, Committee I, Goldstraw P, Rami-Porta R, Asamura H, Ball D, Beer D, Beyruti R, Bolejack V, Chansky K, Crowley J, Detterbeck F, Eberhardt W, Edwards J, Galateau-Sallé F, Giroux D, Gleeson F, Groome P, Huang J, Kennedy C, Kim J, Kim Y, Kingsbury L, Kondo H, Krasnik M, Kubota K, Lerut A, Lyons G, Marino M, Marom E, van Meerbeeck J, Mitchell A, Nakano T, Nicholson A, Nowak A, Peake M, Rice T, Rosenzweig K, Ruffini E, Rusch V, Saijo N, Van Schil P, Sculier J, Shemanski L, Stratton K, Suzuki K, Tachimori Y, Thomas C, Travis W, Tsao M, Turrisi A, Vansteenkiste J, Watanabe H, Wu Y, Boards A, Baas P, Erasmus J, Hasegawa S, Inai K, Kernstine K, Kindler H, Krug L, Nackaerts K, Pass H, Rice D, Falkson C, Filosso P, Giaccone G, Kondo K, Lucchi M, Okumura M, Blackstone E, Workgroup M, Flieder D, Godoy M, Goo J, Goodman L, Jett J, de Leyn P, Marchevsky A, MacMahon H, Naidich D, Okada M, Perlman M, Powell C, van Schil P, Warth A, Institutions P, Cavaco F, Barrera E, Arca J, Lamelas I, Obrer A, Jorge R, Ball D, Bascom G, Orozco A, Castro M, Blum M, Chimondeguy D, Cvijanovic V, Defranchi S, de Olaiz Navarro B, Campuzano I, Vidueira I, Araujo E, García F, Fong K, Corral G, González S, Gilart J, Arangüena L, Barajas S, Girard P, Goksel T, Budiño M, Casaurrán G, Blanco J, Hernández J, Rodríguez H, Collantes J, Heras M, Elena J, Jakobsen E, Kostas S, Atance P, Ares A, Liao M, Losanovscky M, Lyons G, Magaroles R, De Esteban Júlvez L, Gorospe M, McCaughan B, Kennedy C, Íñiguez R, Sorribes L, Gozalo S, de Arriba C, Delgado M, Alarcón J, Cuesta J, Park J, Pass H, Fernández M, Rosenberg M, Ruffini E, Rusch V, de Cos Escuín J, Vinuesa A, Mitjans M, Strand T, Subotic D, Swisher S, Terra R, Thomas C, Tournoy K, Van Schil P, Velasquez M, Wu Y, Yokoi K. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer Journal Of Thoracic Oncology 2016, 11: 681-692. PMID: 26940530, DOI: 10.1016/j.jtho.2015.12.114.
• The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM ClassificationDetterbeck FC, Marom EM, Arenberg DA, Franklin WA, Nicholson AG, Travis WD, Girard N, Mazzone PJ, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R, Committee I, Goldstraw P, Rami-Porta R, Asamura H, Ball D, Beer D, Beyruti R, Bolejack V, Chansky K, Crowley J, Detterbeck F, Eberhardt W, Edwards J, Galateau-Sallé F, Giroux D, Gleeson F, Groome P, Huang J, Kennedy C, Kim J, Kim Y, Kingsbury L, Kondo H, Krasnik M, Kubota K, Lerut A, Lyons G, Marino M, Marom E, van Meerbeeck J, Mitchell A, Nakano T, Nicholson A, Nowak A, Peake M, Rice T, Rosenzweig K, Ruffini E, Rusch V, Saijo N, Van Schil P, Sculier J, Shemanski L, Stratton K, Suzuki K, Tachimori Y, Thomas C, Travis W, Tsao M, Turrisi A, Vansteenkiste J, Watanabe H, Wu Y, Boards A, Baas P, Erasmus J, Hasegawa S, Inai K, Kernstine K, Kindler H, Krug L, Nackaerts K, Pass H, Rice D, Falkson C, Filosso P, Giaccone G, Kondo K, Lucchi M, Okumura M, Blackstone E, Workgroup M, Flieder D, Godoy M, Goo J, Goodman L, Jett J, de Leyn P, Marchevsky A, MacMahon H, Naidich D, Okada M, Perlman M, Powell C, van Schil P, Warth A. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification Journal Of Thoracic Oncology 2016, 11: 666-680. PMID: 26940527, DOI: 10.1016/j.jtho.2015.12.113.
• The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM ClassificationDetterbeck FC, Nicholson AG, Franklin WA, Marom EM, Travis WD, Girard N, Arenberg DA, Bolejack V, Donington JS, Mazzone PJ, Tanoue LT, Rusch VW, Crowley J, Asamura H, Rami-Porta R, Committee I, Goldstraw P, Rami-Porta R, Asamura H, Ball D, Beer D, Beyruti R, Bolejack V, Chansky K, Crowley J, Detterbeck F, Eberhardt W, Edwards J, Galateau-Sallé F, Giroux D, Gleeson F, Groome P, Huang J, Kennedy C, Kim J, Kim Y, Kingsbury L, Kondo H, Krasnik M, Kubota K, Lerut A, Lyons G, Marino M, Marom E, van Meerbeeck J, Mitchell A, Nakano T, Nicholson A, Nowak A, Peake M, Rice T, Rosenzweig K, Ruffini E, Rusch V, Saijo N, Van Schil P, Sculier J, Shemanski L, Stratton K, Suzuki K, Tachimori Y, Thomas C, Travis W, Tsao M, Turrisi A, Vansteenkiste J, Watanabe H, Wu Y, Boards A, Baas P, Erasmus J, Hasegawa S, Inai K, Kernstine K, Kindler H, Krug L, Nackaerts K, Pass H, Rice D, Falkson C, Filosso P, Giaccone G, Kondo K, Lucchi M, Okumura M, Blackstone E, Workgroup M, Flieder D, Godoy M, Goo J, Goodman L, Jett J, de Leyn P, Marchevsky A, MacMahon H, Naidich D, Okada M, Perlman M, Powell C, van Schil P, Warth A, Institutions P, Cavaco F, Barrera E, Arca J, Lamelas I, Obrer A, Jorge R, Ball D, Bascom G, Orozco A, Castro M, Blum M, Chimondeguy D, Cvijanovic V, Defranchi S, de Olaiz Navarro B, Campuzano I, Vidueira I, Araujo E, García F, Fong K, Corral G, González S, Gilart J, Arangüena L, Barajas S, Girard P, Goksel T, Budiño M, Casaurrán G, Blanco J, Hernández J, Rodríguez H, Collantes J, Heras M, Elena J, Jakobsen E, Kostas S, Atance P, Ares A, Liao M, Losanovscky M, Lyons G, Magaroles R, De Esteban Júlvez L, Gorospe M, McCaughan B, Kennedy C, Íñiguez R, Sorribes L, Gozalo S, de Arriba C, Delgado M, Alarcón J, Cuesta J, Park J, Pass H, Fernández M, Rosenberg M, Ruffini E, Rusch V, de Cos Escuín J, Vinuesa A, Mitjans M, Strand T, Subotic D, Swisher S, Terra R, Thomas C, Tournoy K, Van Schil P, Velasquez M, Wu Y, Yokoi K. The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification Journal Of Thoracic Oncology 2016, 11: 639-650. PMID: 26940528, DOI: 10.1016/j.jtho.2016.01.024.
• The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung CancerDetterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, Mazzone PJ, Marom EM, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R, Committee I, Goldstraw P, Rami-Porta R, Asamura H, Ball D, Beer D, Beyruti R, Bolejack V, Chansky K, Crowley J, Detterbeck F, Eberhardt W, Edwards J, Galateau-Sallé F, Giroux D, Gleeson F, Groome P, Huang J, Kennedy C, Kim J, Kim Y, Kingsbury L, Kondo H, Krasnik M, Kubota K, Lerut A, Lyons G, Marino M, Marom E, van Meerbeeck J, Mitchell A, Nakano T, Nicholson A, Nowak A, Peake M, Rice T, Rosenzweig K, Ruffini E, Rusch V, Saijo N, Van Schil P, Sculier J, Shemanski L, Stratton K, Suzuki K, Tachimori Y, Thomas C, Travis W, Tsao M, Turrisi A, Vansteenkiste J, Watanabe H, Wu Y, Boards A, Baas P, Erasmus J, Hasegawa S, Inai K, Kernstine K, Kindler H, Krug L, Nackaerts K, Pass H, Rice D, Falkson C, Filosso P, Giaccone G, Kondo K, Lucchi M, Okumura M, Blackstone E, Workgroup M, Flieder D, Godoy M, Goo J, Goodman L, Jett J, de Leyn P, Marchevsky A, MacMahon H, Naidich D, Okada M, Perlman M, Powell C, van Schil P, Warth A. The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer Journal Of Thoracic Oncology 2016, 11: 651-665. PMID: 26944304, DOI: 10.1016/j.jtho.2016.01.025.
• Reply: Lung Cancer Screening: The Balance between Harm and BenefitTanoue LT, Tanner NT, Gould MK, Silvestri GA. Reply: Lung Cancer Screening: The Balance between Harm and Benefit American Journal Of Respiratory And Critical Care Medicine 2015, 191: 1209-1210. PMID: 25978579, DOI: 10.1164/rccm.201503-0526le.
• Effects of One-Hour Training Course and Spirometry on the Ability of Physicians to Diagnose and Treat Chronic Obstructive Pulmonary DiseaseCai S, Qin L, Tanoue L, Hu A, Jia X, Luo H, Chen Y, Chen P, Peng H. Effects of One-Hour Training Course and Spirometry on the Ability of Physicians to Diagnose and Treat Chronic Obstructive Pulmonary Disease PLOS ONE 2015, 10: e0117348. PMID: 25706774, PMCID: PMC4338104, DOI: 10.1371/journal.pone.0117348.
• Lung Cancer ScreeningTanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung Cancer Screening American Journal Of Respiratory And Critical Care Medicine 2015, 191: 19-33. PMID: 25369325, DOI: 10.1164/rccm.201410-1777ci.
• The Role of the Advanced Practitioner in a Comprehensive Lung Cancer Screening and Pulmonary Nodule ProgramReid AE, Tanoue L, Detterbeck F, Michaud GC, McCorkle R. The Role of the Advanced Practitioner in a Comprehensive Lung Cancer Screening and Pulmonary Nodule Program Journal Of The Advanced Practitioner In Oncology 2014, 5: 440-446. PMID: 26328217, PMCID: PMC4530114, DOI: 10.6004/jadpro.2014.5.6.4.
• Surveillance Practice Patterns After Curative Intent Therapy for Stage I Non-small Cell Lung Cancer in the Medicare PopulationErb C, Soulos P, Tanoue L, Gross C. Surveillance Practice Patterns After Curative Intent Therapy for Stage I Non-small Cell Lung Cancer in the Medicare Population CHEST Journal 2014, 146: 607a. DOI: 10.1378/chest.1992085.
• Physicians' Assessment of Lung Cancer Risk and the Influence of Prediction Models on Decisions Relating to Lung ScreeningReid A, Detterbeck F, Michaud G, Guillod P, Tanoue L. Physicians' Assessment of Lung Cancer Risk and the Influence of Prediction Models on Decisions Relating to Lung Screening CHEST Journal 2013, 144: 648a-648b. DOI: 10.1378/chest.1662734.
• Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSilvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, Detterbeck FC. Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines CHEST Journal 2013, 143: e211s-e250s. PMID: 23649440, DOI: 10.1378/chest.12-2355.
• Clinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesOst DE, Yeung SC, Tanoue LT, Gould MK. Clinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines CHEST Journal 2013, 143: e121s-e141s. PMID: 23649435, PMCID: PMC4694609, DOI: 10.1378/chest.12-2352.
• The Stage Classification of Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDetterbeck FC, Postmus PE, Tanoue LT. The Stage Classification of Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines CHEST Journal 2013, 143: e191s-e210s. PMID: 23649438, DOI: 10.1378/chest.12-2354.
• National comprehensive cancer network.Detterbeck F, Tanoue L, Reid A. National comprehensive cancer network. Journal Of The National Comprehensive Cancer Network 2013, 11: 365-6. PMID: 23584338, DOI: 10.6004/jnccn.2013.0050.
• Use of New Treatment Modalities for Non-small Cell Lung Cancer Care in the Medicare PopulationVest MT, Herrin J, Soulos PR, Decker RH, Tanoue L, Michaud G, Kim AW, Detterbeck F, Morgensztern D, Gross CP. Use of New Treatment Modalities for Non-small Cell Lung Cancer Care in the Medicare Population CHEST Journal 2013, 143: 429-435. PMID: 23187634, PMCID: PMC3566996, DOI: 10.1378/chest.12-1149.
• Effect Of Short-Term Education And Spirometry On The Diagnosis Of Chronic Obstructive Pulmonary Disease In 2nd Level Hospitals In Hunan, ChinaCai S, Liu F, Hu A, Chen P, Tanoue L. Effect Of Short-Term Education And Spirometry On The Diagnosis Of Chronic Obstructive Pulmonary Disease In 2nd Level Hospitals In Hunan, China 2012, a3711-a3711. DOI: 10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3711.
• Thoroughness of Mediastinal Staging in Stage IIIA Non-small Cell Lung CancerVest MT, Tanoue L, Soulos PR, Kim AW, Detterbeck F, Morgensztern D, Gross CP. Thoroughness of Mediastinal Staging in Stage IIIA Non-small Cell Lung Cancer Journal Of Thoracic Oncology 2012, 7: 188-195. PMID: 22134069, PMCID: PMC3253367, DOI: 10.1097/jto.0b013e318236ecbb.
• Lung Cancer: Epidemiology, Etiology, and PreventionDela Cruz CS, Tanoue LT, Matthay RA. Lung Cancer: Epidemiology, Etiology, and Prevention Clinics In Chest Medicine 2011, 32: 605-644. PMID: 22054876, PMCID: PMC3864624, DOI: 10.1016/j.ccm.2011.09.001.
• PrefaceTanoue L, Matthay R. Preface Clinics In Chest Medicine 2011, 32: xiii-xiv. DOI: 10.1016/j.ccm.2011.08.016.
• Lung Cancer in Older PatientsGettinger S, Tanoue L. Lung Cancer in Older Patients 2011, 89-109. DOI: 10.1007/978-1-60761-727-3_5.
• Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assayAnagnostou VK, Dimou AT, Botsis T, Killiam EJ, Gustavson MD, Homer RJ, Boffa D, Zolota V, Dougenis D, Tanoue L, Gettinger SN, Detterbeck FC, Syrigos KN, Bepler G, Rimm DL. Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assay Cancer 2011, 118: 1607-1618. PMID: 22009766, DOI: 10.1002/cncr.26450.
• Adoption Of Invasive Clinical Staging Techniques In Stage IIIA Non-Small Cell Lung Cancer Lags Adoption Of Positron Emission TomographyVest M, Tanoue L, Soulos P, Kim A, Gross C. Adoption Of Invasive Clinical Staging Techniques In Stage IIIA Non-Small Cell Lung Cancer Lags Adoption Of Positron Emission Tomography 2011, a5380-a5380. DOI: 10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5380.
• Lung CancerTanoue, LT. Lung Cancer. In Yearbook of Pulmonary Medicine 2011. JA Barker, Ed. Elsevier Mosby, Philadelphia. 2011, pp 61-106.
• Lung Cancer in Older Patients.Gettinger S. and Tanoue, LT. Lung Cancer in Older Patients. In Aging and Lung Diseases, M. Pisani Ed, Springer, New York, 2011, pp 89-110.
• Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer?Boffa DJ, Detterbeck FC, Smith EJ, Rami-Porta R, Crowley J, Zelterman D, Tanoue L, Kim AW, Goldstraw P. Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer? Journal Of Thoracic Oncology 2010, 5: 1779-1783. PMID: 20975377, DOI: 10.1097/jto.0b013e3181ee80c7.
• Molecular classification of non-small cell lung cancer using a four protein quantitative assay.Anagnostou V, Botsis T, Killiam E, Zolota V, Dougenis D, Tanoue L, Detterbeck F, Syrigos K, Bepler G, Rimm D. Molecular classification of non-small cell lung cancer using a four protein quantitative assay. Journal Of Clinical Oncology 2010, 28: 10528-10528. DOI: 10.1200/jco.2010.28.15_suppl.10528.
• High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histologyAnagnostou VK, Lowery FJ, Zolota V, Tzelepi V, Gopinath A, Liceaga C, Panagopoulos N, Frangia K, Tanoue L, Boffa D, Gettinger S, Detterbeck F, Homer RJ, Dougenis D, Rimm DL, Syrigos KN. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology BMC Cancer 2010, 10: 186. PMID: 20459695, PMCID: PMC2875218, DOI: 10.1186/1471-2407-10-186.
• Details and Difficulties Regarding the New Lung Cancer Staging SystemDetterbeck FC, Boffa DJ, Tanoue LT, Wilson LD. Details and Difficulties Regarding the New Lung Cancer Staging System CHEST Journal 2010, 137: 1172-1180. PMID: 20442118, DOI: 10.1378/chest.09-2626.
• Abstract 4643: A novel 3-biomarker quantitative protein assay predicts survival in stage I lung squamous cell carcinomasAnagnostou V, Kolokytha P, Dimou A, Killiam E, Zolota V, Dougenis D, Frangia K, Tanoue L, Detterbeck F, Syrigos K, Bepler G, Rimm D. Abstract 4643: A novel 3-biomarker quantitative protein assay predicts survival in stage I lung squamous cell carcinomas Cancer Research 2010, 70: 4643-4643. DOI: 10.1158/1538-7445.am10-4643.
• Lung CancerTanoue. LT. Lung Cancer. In Breathing in America: Diseases, Progress, and Hope. Ed. De Schraufnagel. American Thoracic Society 2010, pp. 109-120.
• Anatomy, Biology and Concepts, Pertaining to Lung Cancer Stage ClassifcationDETTERBECK FC, TANOUE LT, BOFFA DJ, 杨 永, 李 志. Anatomy, Biology and Concepts, Pertaining to Lung Cancer Stage Classifcation Chinese Journal Of Lung Cancer 2010, 13: 1-8. PMID: 20672696, PMCID: PMC6136057, DOI: 10.3779/j.issn.1009-3419.2010.01.01.
• The New Lung Cancer Staging SystemDetterbeck FC, Boffa DJ, Tanoue LT. The New Lung Cancer Staging System CHEST Journal 2009, 136: 260-271. PMID: 19584208, DOI: 10.1378/chest.08-0978.
• High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung AdenocarcinomaAnagnostou VK, Bepler G, Syrigos KN, Tanoue L, Gettinger S, Homer RJ, Boffa D, Detterbeck F, Rimm DL. High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma Clinical Cancer Research 2009, 15: 4157-4164. PMID: 19509151, DOI: 10.1158/1078-0432.ccr-09-0099.
• Association of expression of bcl-2 with outcome in non-small cell lung cancerAnagnostou V, Lowery F, Syrigos K, Frangia K, Zolota V, Panagopoulos N, Dougenis D, Tanoue L, Detterbeck F, Homer R, Rimm D. Association of expression of bcl-2 with outcome in non-small cell lung cancer Journal Of Clinical Oncology 2009, 27: e22039-e22039. DOI: 10.1200/jco.2009.27.15_suppl.e22039.
• Anatomy, Biology and Concepts, Pertaining to Lung Cancer Stage ClassificationDetterbeck FC, Tanoue LT, Boffa DJ. Anatomy, Biology and Concepts, Pertaining to Lung Cancer Stage Classification Journal Of Thoracic Oncology 2009, 4: 437-443. PMID: 19333070, DOI: 10.1097/jto.0b013e31819852ed.
• New TNM classification for non-small-cell lung cancerTanoue LT, Detterbeck FC. New TNM classification for non-small-cell lung cancer Expert Review Of Anticancer Therapy 2009, 9: 413-423. PMID: 19374596, DOI: 10.1586/era.09.11.
• Pulmonary Problems in Lung Cancer SurvivorsMiller K and Tanoue LT. Pulmonary Problems in Lung Cancer Survivors. In Medical and Psychosocial Care of the Cancer Survivor. KD Miller, Ed. Jones and Bartlett Publishers, Sudbury, MA. 2009, pp 299-312.
• Lung Cancer: Epidemiology and Carcinogenesis.Dela Cruz C, Tanoue LT, and Matthay RT. Lung Cancer: Epidemiology and Carcinogenesis. In General Thoracic Surgery, Seventh Edition; Shields TW, Locicero J III, Reed CD, and Feins RH, and Rusch VW, Eds. Lippincott, Williams & Wilkins, Philadelphia. 2009, pp 1281-1298.
• Lung Cancer: Evolving ConceptsSilvestri G, Tanoue L. Lung Cancer: Evolving Concepts Seminars In Respiratory And Critical Care Medicine 2008, 29: 221-222. PMID: 18506659, DOI: 10.1055/s-2008-1076741.
• Staging of Non-Small Cell Lung CancerTanoue LT. Staging of Non-Small Cell Lung Cancer Seminars In Respiratory And Critical Care Medicine 2008, 29: 248-260. PMID: 18506663, DOI: 10.1055/s-2008-1076745.
• IntroductionTanoue L. Introduction Yearbook Of Pulmonary Disease 2008, 2008: 99-101. DOI: 10.1016/s8756-3452(08)70592-9.
• Treatment of Lung Cancer in Older PatientsTanoue LT, Gettinger S. Treatment of Lung Cancer in Older Patients Clinics In Chest Medicine 2007, 28: 735-749. PMID: 17967291, DOI: 10.1016/j.ccm.2007.08.003.
• Massive Intravascular Hemolysis and a Rapidly Fatal OutcomeKapoor JR, Monteiro B, Tanoue L, Siegel MD. Massive Intravascular Hemolysis and a Rapidly Fatal Outcome CHEST Journal 2007, 132: 2016-2019. PMID: 18079238, DOI: 10.1378/chest.07-0853.
• Noninvasive Staging of Non-small Cell Lung Cancer ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F. Noninvasive Staging of Non-small Cell Lung Cancer ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) CHEST Journal 2007, 132: 178s-201s. PMID: 17873168, DOI: 10.1378/chest.07-1360.
• Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities.Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD. Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities. Oncology 2006, 20: 899-905; discussion 905-8, 913. PMID: 16922260.
• Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy.Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD. Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy. Oncology 2006, 20: 727-36. PMID: 16841796.
• High Rate of Negative Results of Tuberculin and QuantiFERON Tests Among Individuals With a History of Positive Skin Test ResultsFriedman LN, Nash ER, Bryant J, Henry S, Shi J, D'Amato J, Khaled GH, Russi MB, O'Connor PG, Edberg SC, Pisani MA, Cain HC, Tanoue L, Weissman DN. High Rate of Negative Results of Tuberculin and QuantiFERON Tests Among Individuals With a History of Positive Skin Test Results Infection Control And Hospital Epidemiology 2006, 27: 436-441. PMID: 16671022, DOI: 10.1086/503690.
• Case Study ReviewNoble PW, Tanoue L, Homer R. Case Study Review CHEST Journal 2005, 128: 540s-546s. PMID: 16304245, DOI: 10.1378/chest.128.5_suppl_1.540s.
• The Noninvasive Staging of Non-small Cell Lung Cancer* The GuidelinesSilvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The Noninvasive Staging of Non-small Cell Lung Cancer* The Guidelines CHEST Journal 2003, 123: 147s-156s. PMID: 12527574, DOI: 10.1378/chest.123.1_suppl.147s.
• Pulmonary Hypertension in the Collagen Vascular DiseasesTanoue LT. Pulmonary Hypertension in the Collagen Vascular Diseases Seminars In Respiratory And Critical Care Medicine 2003, 24: 287-296. PMID: 16088549, DOI: 10.1055/s-2003-41089.
• Therapy for stage I and stage II non-small cell lung cancerTanoue LT, Ponn RB. Therapy for stage I and stage II non-small cell lung cancer Clinics In Chest Medicine 2002, 23: 173-190. PMID: 11901910, DOI: 10.1016/s0272-5231(03)00067-4.
• CIGARETTE SMOKING AND WOMEN'S RESPIRATORY HEALTHTanoue LT. CIGARETTE SMOKING AND WOMEN'S RESPIRATORY HEALTH Clinics In Chest Medicine 2000, 21: 47-65. PMID: 10763089, DOI: 10.1016/s0272-5231(05)70007-1.
• Use of neodymium yttrium aluminum garnet laser in long-term palliation of airway obstruction.Quin JA, Letsou GV, Tanoue LT, Matthay RA, Higgins RS, Baldwin JC. Use of neodymium yttrium aluminum garnet laser in long-term palliation of airway obstruction. Connecticut Medicine 1995, 59: 407-12. PMID: 7545564.
• Vitamin A Chemoprevention of Lung CancerRedlich C, Van Bennekum A, Wirth J, Blaner W, Carter D, Tanoue L, Holm C, Cullen M. Vitamin A Chemoprevention of Lung Cancer 1995, 375: 17-29. PMID: 7645426, DOI: 10.1007/978-1-4899-0949-7_2.
• The effect of diuretics on extrarenal potassium tolerance.Tanoue LT, Aronson PS, Bia MJ. The effect of diuretics on extrarenal potassium tolerance. The Yale Journal Of Biology And Medicine 1982, 55: 421-8. PMID: 7183021, PMCID: PMC2596565.
• Pulmonary Toxicity Associated With Chemotherapeutic Agents.Tanoue LT and McArdle J. Pulmonary Toxicity Associated With Chemotherapeutic Agents. In Fishman’s Textbook of Pulmonary Disorders and Diseases, 3rd Edition, A.P.Fishman, Ed., McGraw Hill, Inc., New York, pp 1067-1102.
• Lung Cancer: Clinical Evaluation and StagingTanoue, LT. “Lung Cancer: Clinical Evaluation and Staging”, in Comprehensive Respiratory Medicine, Ed. SG Spiro SG and G Silvestri, Mosby, London, in press.